Symbol Lookup

Sunday March 29, 2015 4:42 PM ET. Data delayed 15 minutes.
10.13
0.83 (8.92%)
Bid/Lots
10.11/10
Ask/Lots
10.13/2
Open/Prev Close
10.00/9.30
Day Range
9.54-10.36
52-Week Range
7.53-20.70
Vol/Avg Daily Vol
374.1K/174.7K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Cara Therapeutics Posts Narrower-than-Expected Q4 Loss, Sales Top Views
5:06PM ET on Thursday Mar 26, 2015 by Midnight Trader
Companies Mentioned: CARA
05:06 PM EDT, 03/26/2015 (MT Newswires) -- Cara Therapeutics (CARA) reported late Thursday a narrower-than-expected net loss in Q4 on slightly lower revenues that still topped the consensus of analysts polled by Capital IQ. The Connecticut-based bi...
05:06 PM EDT, 03/26/2015 (MT Newswires) -- Cara Therapeutics (CARA) reported late Thursday a narrower-than-expected net loss in Q4 on slightly lower revenues that still topped the consensus of analysts polled by Capital IQ. The Connecticut-based...
Cara Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
4:01PM ET on Thursday Mar 26, 2015 by GlobeNewswire
Companies Mentioned: CARA

- Phase 3 pivotal trials for I.V. CR845 expected to initiate during second quarter of 2015, following scheduled End-of-Phase 2 Meeting -

- Reported positive top-line data from human abuse liability trial of I.V. CR845 for the treatment of acute pain -

- Phase 3 pivotal trials for I.V. CR845 expected to initiate during second quarter of 2015, following scheduled End-of-Phase 2 Meeting -

- Reported positive top-line data from human abuse liability trial of I.V. CR845 for the treatment o...

Mar 19, 2015

Cara Therapeutics to Sponsor Symposium and Present Poster at the American Academy of Pain Medicine's 31st Annual Meeting
5:00PM ET on Thursday Mar 19, 2015 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that it is sponsoring and participating in a breakfast symposium titled "Old problems, new solutions. What's next for people in pain?" at the American Academy of Pain Medicine's 31 Annual Meeting in National Harbor, Maryland. Leading experts will discuss the latest developments in pain treatment, including data from Cara's human abuse liability study of I.V. CR845, the Company's first-in-class peripherally-selective kappa opioid agonist which has potential to be the first Schedule V or non-scheduled opioid for acute pain.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that it is s...

Cara Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results on March 26, 2015
8:00AM ET on Thursday Mar 19, 2015 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, March 26, 2015, at 4:30 p.m. ET to report fourth quarter and full year 2014 financial results and provide a corporate update.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that the Com...

Mar 13, 2015

Cara Therapeutics to Webcast Presentation at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference
8:00AM ET on Friday Mar 13, 2015 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 22 Annual BioCentury Future Leaders in the Biotech Industry Conference on Friday, March 20, 2015, at 2:00 p.m. ET in New York City.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr....

← Newer12Older →

Peers Headlines

Mar 26, 2015

Analyst Actions: Egalet Price Target Raised To $24 At JMP Securities, Reiterated Market Outperform
2:18PM ET on Thursday Mar 26, 2015 by Midnight Trader
Companies Mentioned: EGLT
02:18 PM EDT, 03/26/2015 (MT Newswires) -- Egalet (EGLT) saw its price target boosted to $24 from $18 by JMP Securities while the firm retained its market outperform rating on the stock. Price: 14.32, Change: -0.01, Percent Change: -0.07 ...

Mar 19, 2015

Athersys to Participate at 12th Annual BIO Asia International Conference
1:00PM ET on Thursday Mar 19, 2015 by GlobeNewswire
Companies Mentioned: ATHX

Athersys, Inc. (Nasdaq:ATHX) announced today that it will be participating in the 12 annual BIO Asia International Conference to be held on March 24-25, 2015 at the Grand Hyatt, Tokyo, Japan. Athersys is additionally a conference sponsor.

Mar 18, 2015

Midday Update: Wall Street Extending Equity Losses Before FOMC Statement
12:44PM ET on Wednesday Mar 18, 2015 by Midnight Trader
Companies Mentioned: GDX, GLD, KO, MSCC, NKTR, NVGN, SYRX, TEVA, FXCM, VTSS, ADBE, RTRX, USO, SLV, BA, RXDX, RSPP, CBRX, UNG
12:44 PM EDT, 03/18/2015 (MT Newswires) -- Stocks were adding to yesterday's losses as Wall Street braces for a decision this afternoon by the Federal Open Market Committee on U.S. monetary policy and a potential rise in short-term interest rates...
U.S. Stocks Set for Lower Open Ahead of Federal Reserve Rate Announcement
9:03AM ET on Wednesday Mar 18, 2015 by Midnight Trader
Companies Mentioned: FDX, JPM, MSCC, NKTR, ANTH, TEVA, VRTX, VTSS, P, ADBE, AKRX, RTRX, RXDX, ESPR, BGC, RSPP, BABA, HUBS, CRR, ATNM
09:03 AM EDT, 03/18/2015 (MT Newswires) -- U.S. stocks were set to open lower Wednesday as markets readied to parse the Federal Open Market Committee's monetary policy statement in the afternoon for clues as to an interest-rate increase. The FOMC...
Asterias Biotherapeutics to Present at Regen Med Investor Day 2015
7:00AM ET on Wednesday Mar 18, 2015 by PR Newswire
Companies Mentioned: AST

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, today announced that Pedro Lichtinger, President and Chief Executive Officer of Asterias, will present at the Regen ...

Ignyta Buys Rights to Teva Oncology Assets In Exchange for Stock
6:44AM ET on Wednesday Mar 18, 2015 by Midnight Trader
Companies Mentioned: TEVA, RXDX
06:44 AM EDT, 03/18/2015 (MT Newswires) -- Ignyta (RXDX) and Teva (TEVA) said late Tuesday RXDX bought worldwide rights and assets relating to four targeted oncology development programs in exchange for 1.5 million shares (6%) of RXDX's common st...

Mar 17, 2015

Ignyta Announces 2014 Full Year Company Highlights and Financial Results
4:15PM ET on Tuesday Mar 17, 2015 by Business Wire
Companies Mentioned: RXDX

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced company highlights and financial results for the full year ended December 31, 2014.

"Since the beginning of 2014, we have made signifi...

Mar 16, 2015

Egalet Reports Full Year 2014 Financial Results
6:00AM ET on Monday Mar 16, 2015 by PR Newswire
Companies Mentioned: EGLT

Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported financial results for the year ended December 31, 2014.

http://photos.prnewswire.com/prnvar/20140219/NY67493LOGO

2014 Financial Results:

-- Cash Position: Cash as ...

Mar 12, 2015

MT Newswires After-Hours News Movers
5:41PM ET on Thursday Mar 12, 2015 by Midnight Trader
Companies Mentioned: ZUMZ, MED, PPHM, CYTX, JMBA, FXCM, KTOS, ARO, ATHX, CBI, LOCO, ULTA
05:41 PM EDT, 03/12/2015 (MT Newswires) -- Some of the stocks moving on news-driven events in Thursday's after-hours include: LOCO, +9.6% ULTA, +7.6% JMBA, +4.6% FXCM, +4.2% ATHX, +3.5% PPHM, +2.3% KTOS, +0.2% CYTX, -13.1% ARO, -10.3% MED, -8.4% ...
Athersys Q4 Sales Falls Vs Yr Ago But Net Loss Narrows
4:11PM ET on Thursday Mar 12, 2015 by Midnight Trader
Companies Mentioned: ATHX
04:11 PM EDT, 03/12/2015 (MT Newswires) -- Athersys (ATHX) says Q4 sales were $0.2 million and net loss was $6.6 million. Sales were down from $0.9 million in sales in the year-ago period and net loss was narrower than a loss of $9.8 million last...
← Newer123Older →